By Professor Alison Ritter

Journal articles

Ritter A; Cameron J, 2006, 'A review of the efficacy and effectiveness of harm reduction strategies for alcohol, tobacco and illicit drugs', Drug and Alcohol Review, 25, pp. 611 - 624, http://dx.doi.org/10.1080/09595230600944529

Ritter A, 2006, 'Drug and Alcohol Review: Editorial', Drug and Alcohol Review, 25, pp. 391 - 392, http://dx.doi.org/10.1080/09595230600919471

Digiusto EA; Shakeshaft AP; Ritter A; Mattick RP; White J; Lintzeris N; Bell JR; Saunders J, 2006, 'Effects of pharmacotherapies for opioid dependence on participants` criminal behaviour and expenditure on illicit drugs: An Australian National Evaluation (NEPOD)', Australian and New Zealand Journal of Criminology, 39, pp. 171 - 189

O Brien SM; Mattick RP; White J; Breen CL; Kimber J; Ritter A; Lintzeris N, 2006, 'Maintenance Pharmacotherapy for Opioid Dependence and SR-36 Health Status: A Comparison with General Population Norms and Other Chronic Disorders', Addictive Disorders and Their Treatment, 5, pp. 155 - 164

Teesson M; Ross JE; Darke S; Lynskey M; Ali RL; Ritter A, 2006, 'One year outcomes for heroin dependence: Findings from the Australian Treatment Outcome Study (ATOS)', Drug and Alcohol Dependence, 83, pp. 174 - 180

Ross JE; Teesson M; Darke S; Lynskey MT; Ali RL; Ritter A; Cooke R, 2006, 'Short-term Outcomes for the Treatment of Heroin Dependence: Findings From the Australian Treatment Outcome Study (ATOS)', , 5, pp. 133 - 143, http://dx.doi.org/10.1097/01.adt.0000210717.33564.a8

Ritter A, 2006, 'Study illicit drug markets: Disciplinary contributions', International Journal of Drug Policy, 17, pp. 453 - 463

Ritter A, 2006, 'Studying illicit drug markets: Disciplinary contributions', International Journal of Drug Policy, 17, pp. 453 - 463

Fry CL; Hall W; Ritter A; Jenkinson R, 2006, 'The ethics of paying drug users who participate in research: A review and practical recommendations', JOURNAL OF EMPIRICAL RESEARCH ON HUMAN RESEARCH ETHICS, 1, pp. 21 - 35, http://dx.doi.org/10.1525/jer.2006.1.4.21

Fry CL; Ritter A; Bowen KJ; Gardiner P; Holt T; Jenkinson R; Johnston J; Baldwin S, 2005, 'Paying research participants: A study of current practices in Australia', Journal of Medical Ethics, 31, pp. 542 - 547, http://dx.doi.org/10.1136/jme.2004.009290

Ritter A; Natale RDI, 2005, 'The relationship between take-away methadone policies and methadone diversion', Drug and Alcohol Review, 24, pp. 347 - 352, http://dx.doi.org/10.1080/09595230500263939

Harris AH; Gospodarevskaya E; Ritter AJ, 2005, 'A randomised trial of the cost effectiveness of buprenorphine as an alternative to methadone maintenance treatment for heroin dependence in a primary care setting', Pharmacoeconomics, 23, pp. 77 - 91, http://dx.doi.org/10.2165/00019053-200523010-00007

Ritter AJ; Wodak AD; Crofts JN, 2005, 'Reducing drug-related harm: Australia leads the way - Reply', MEDICAL JOURNAL OF AUSTRALIA, 182, pp. 141 - 141, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000227346100023&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Caldicott DGE; Duff C; Ritter AJ; Wodak AD; Crofts JN, 2005, 'Reducing drug-related harm: Australia leads the way (multiple letters) [6]', Medical Journal of Australia, 182, pp. 140 - 141, http://dx.doi.org/10.5694/j.1326-5377.2005.tb06624.x

Digiusto E; Shakeshaft A; Ritter A; O'Brien S; Mattick RP, 2005, 'Erratum: Serious adverse events in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD) (Addiction (2004) 99 (450-460))', Addiction, 100, pp. 139, http://dx.doi.org/10.1111/j.1360-0443.2004.01004.x

Digiusto E; Shakeshaft A; Ritter A; O'Brien S; Mattick RP, 2005, 'Serious adverse events in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD) (vol 99, pg 450, 2004)', ADDICTION, 100, pp. 139 - 139, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000226487800031&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Darke S; Ross JE; Teesson M; Ali RL; Cooke R; Ritter A; Lynskey M, 2005, 'Factors associated with 12 months continuous heroin abstinence: findings from the Australian Treatment Outcome Study (ATOS)', Journal of Substance Abuse Treatment, 28, pp. 255 - 263, http://www.sciencedirect.com/science/article/B6T90-4G11GH4-8/2/a7ab2431673d3b3e1517f6bcd5607ca0

Ritter AJ; Wodak AD; Crofts JN, 2005, 'Reducing drug‐related harm: Australia leads the way', Medical Journal of Australia, 182, pp. 140 - 141, http://dx.doi.org/10.5694/j.1326-5377.2005.tb06625.x

Ross JE; Teesson M; Darke S; Lynskey MT; Ali RL; Ritter A; Cooke R, 2005, 'The characteristics of heroin users entering treatment: findings from the Australian Treatment Outcome Study (ATOS)', Drug and Alcohol Review, 24, pp. 411 - 418

Tucker T; Ritter A; Maher C; Jackson H, 2004, 'A randomized control trial of group counseling in a naltrexone treatment program', Journal of Substance Abuse Treatment, 27, pp. 277 - 288, http://dx.doi.org/10.1016/j.jsat.2004.08.003

Ritter AJ; Wodak AD; Crofts JN, 2004, 'Reducing drug-related harm: Australia leads the way', Medical Journal of Australia, 181, pp. 242 - 243, http://dx.doi.org/10.5694/j.1326-5377.2004.tb06260.x

Tucker TK; Ritter AJ; Maher C; Jackson H, 2004, 'Naltrexone maintenance for heroin dependence: Uptake, attrition and retention', Drug and Alcohol Review, 23, pp. 299 - 309, http://dx.doi.org/10.1080/09595230412331289464

Lintzeris N; Ritter A; Panjari M; Clark N; Kutin J; Bammer G, 2004, 'Implementing Buprenorphine Treatment in Community Settings in Australia: Experiences from the Buprenorphine Implementation Trial', American Journal on Addictions, 13, pp. S29 - S41, http://dx.doi.org/10.1080/10550490490440799

Caplehorn J; Ritter A, 2004, 'Comments on Ritter et al.'s report of a comparative trial of laam and methadone maintenance [1] (multiple letters)', Addiction, 99, pp. 509 - 510, http://dx.doi.org/10.1111/j.1360-0443.2004.00682.x

RITTER A, 2004, 'LAAM vs. methadone: a response to Caplehorn', Addiction, 99, pp. 510 - 511, http://dx.doi.org/10.1111/j.1360-0443.2004.00695.x

Tucker T; Fry C; Lintzeris N; Baldwin S; Ritter A; Donath S; Whelan G, 2004, 'Randomized controlled trial of a brief behavioural intervention forreducing hepatitis C virus risk practices among injecting drug users', Addiction, 99, pp. 1157 - 1166

Digiusto EA; Shakeshaft AP; Ritter A; O Brien SM; Mattick RP, 2004, 'Serious adverse events in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD)', Addiction, 99, pp. 450 - 460

Ritter AJ; Lintzeris N; Clark N; Kutin JJ; Bammer G; Panjari M, 2003, 'A randomized trial comparing levo-alpha acetylmethadol with methadone maintenance for patients in primary care settings in Australia', Addiction, 98, pp. 1605 - 1613, http://dx.doi.org/10.1046/j.1360-0443.2003.00529.x

Ritter AJ; Fry CL; Swan A, 2003, 'The ethics of reimbursing injecting drug users for public health research interviews: What price are we prepared to pay?', International Journal of Drug Policy, 14, pp. 1 - 3, http://dx.doi.org/10.1016/S0955-3959(02)00094-4

Breen CL; Harris S; Lintzeris N; Mattick RP; Hawken L; Bell JR; Ritter A; Lenne M; Mendoza E, 2003, 'Cessation of methadone maintenance treatment using uprenorphine: transfer from methadone to buprenorphine and subsequent buprenorphine reductions', Drug and Alcohol Dependence, 71, pp. 49 - 55

Lintzeris N; Dunlop A; Muhleisen P; Ritter A, 2002, 'Training primary health care professionals to prvide Buprenorphine and LAAM treatment', Substance Abuse, 23, pp. 245 - 254, http://dx.doi.org/10.1080/08897070209511497

Ritter A; Bowden S; Murray T; Ross P; Greeley J; Pead J, 2002, 'The influence of the therapeutic relationship in treatment for alcohol dependency', Drug and Alcohol Review, 21, pp. 261 - 268, http://dx.doi.org/10.1080/0959523021000002723

Ritter AJ, 2002, 'Naltrexone in the treatment of heroin dependence: Relationship with depression and risk of overdose', Australian and New Zealand Journal of Psychiatry, 36, pp. 224 - 228, http://dx.doi.org/10.1046/j.1440-1614.2002.01012.x

Wodak AD; Ritter AJ; Watson CRR; Hall WD; Mattick RP; Kimber J, 2002, 'Separating politics and scientific research on heroin prescription (multiple letters)', Medical Journal of Australia, 176, pp. 449 - 450, http://dx.doi.org/10.5694/j.1326-5377.2002.tb04510.x

Clark N; Lintzeris N; Gijsbers A; Whelan G; Dunlop A; Ritter A; Ling W, 2002, 'LAAM maintenance vs methadone maintenance for heroin dependence.', Cochrane Database of Systematic Reviews Online, pp. CD002210

Lintzeris N; Ritter A; Dunlop A; Muhleisen P, 2002, '', Substance Abuse, 23, pp. 245 - 254, http://dx.doi.org/10.1023/a:1021102301285

Dunlop A; Higgs P; Jordens J; Ritter A; Bammer G; Whelan G; Maher L; Higgs P, 2002, 'Vietnamese-Australian heroin users; Ambulatory withdrawal and 24-month follow-up', Addiction Biology, 7, pp. 335 - 335

Bowden SC; Ritter AJ; Carstairs JR; Shores EA; Pead J; Greeley JD; Whelan G; Long CM; Clifford CC, 2001, 'Factorial invariance for combined Wechsler Adult intelligence Scale-Revised and Wechsler Memory Scale-Revised scores in a sample of clients with alcohol dependency', Clinical Neuropsychologist, 15, pp. 69 - 80, http://dx.doi.org/10.1076/clin.15.1.69.1910

Ritter A, 2001, 'Buprenorphine for the treatment of heroin dependence', DRUG AND ALCOHOL REVIEW, 20, pp. 5 - 7, http://dx.doi.org/10.1080/0959523020035240

Lenne M; Lintzeris N; Breen CL; Harris S; Hawken L; Mattick RP; Ritter A, 2001, 'Withdrawal from methadone maintenance treatment: prognosis and participant perspectives', Australian and New Zealand Journal of Public Health, pp. 121 - 125

Tucker TK; Ritter AJ, 2000, 'Naltrexone in the treatment of heroin dependence: A literature review', Drug and Alcohol Review, 19, pp. 73 - 82, http://dx.doi.org/10.1080/09595230096174

Lintzeris N; Lenné M; Ritter A, 1999, 'Methadone injecting in Australia: A tale of two cities', Addiction, 94, pp. 1175 - 1178, http://dx.doi.org/10.1046/j.1360-0443.1999.94811757.x

Ritter A; Lang E; Kutin J; King T; Dietze P, 1999, 'News and Views', Drug and Alcohol Review, 18, pp. 117 - 122, http://dx.doi.org/10.1080/09595239996842

Bowden SC; Fowler KS; Bell RC; Whelan G; Clifford CC; Ritter AJ; Long CM, 1998, 'The reliability and internal validity of the Wisconsin Card Sorting Test', Neuropsychological Rehabilitation, 8, pp. 243 - 254, http://dx.doi.org/10.1080/713755573

Bowden SC; Dodds B; Whelan G; Long C; Dudgeon P; Ritter A; Clifford C, 1997, 'Confirmatory factor analysis of the Wechsler Memory Scale-Revised in a sample of clients with alcohol dependency', Journal of Clinical and Experimental Neuropsychology, 19, pp. 755 - 762, http://dx.doi.org/10.1080/01688639708403757

Bowden SC; Benedikt R; Ritter AJ, 1992, 'Delayed matching to sample and concurrent learning in nonamnesic humans with alcohol dependence', Neuropsychologia, 30, pp. 427 - 435, http://dx.doi.org/10.1016/0028-3932(92)90090-9

RITTER AJ; COLE MJ, 1992, 'Men's issues: gender role conflict and substance abuse', Drug and Alcohol Review, 11, pp. 163 - 167, http://dx.doi.org/10.1080/09595239200185641

Bond NW; Homewood J; Bowden SC; Ritter AJ; Wodak A, 1991, 'Thiamine in our bread and wine [7]', Medical Journal of Australia, 154, pp. 780 - 781, http://dx.doi.org/10.5694/j.1326-5377.1991.tb121339.x

Conference Papers

Wallace R; Stirling R; James D; Nathan S; Ritter A, 2023, 'Improving outcomes for First Nations people in alcohol and other drug treatment', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S180 - S181

Morrison E; Gough C; Stowe MJ; Jauncey M; Ezard N; Henderson C; Ritter A; Nielsen S, 2023, 'Symposium: Safe(r) access for an Australian context: Starting a conversation', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S22 - S23

Back to profile page